Vogt ‐Koyanagi‐Harada disease in pregnancy: Case report and review of 32 patients in the literature

Retinal cross-sectional images of optical coherence tomography at the initial visit (A, B), a week later (C, D), 3  week later (E, F), and 4 weeks later (G, H) from the initial visit. Images in the right eye are in the left column (A, C, E, and G) and images in the left eye are in the right column (B, D, F, and H). Each panel with alphabetical labelling shows color photograph (top left), red-free photograph (bottom left), horizontal section of the image from the nasal to the temporal side (top right), and vertical section of the image from the superior to the inferior side (bottom right). Note sequential decrease of subretinal fluid (arrows in A–F) in 3 weeks after steroid pulse therapy and oral pr ednisolone 20 mg daily, and no subretinal fluid in both eyes (G, H), 4 weeks later from the initial visit. Key Clinical MessageSystemic prednisolone including steroid pulse therapy would be safe in 32 pregnant women, who developed Vogt-Koyanagi-Harada disease in the literature. Prednisolone administration would be shortened by monitoring of serous retinal detachment with optical coherence tomography.AbstractA 30-year-old woman in 31  weeks of pregnancy with metamorphopsia and headache was diagnosed Vogt-Koyanagi-Harada disease. She underwent steroid pulse therapy and oral prednisolone 20 mg daily for 3 weeks until complete resolution of serous retinal detachment monitored by optical coherence tomography. Oral prednisolone was tapered and discontinued until unevent...
Source: Clinical Case Reports - Category: General Medicine Authors: Tags: CASE REPORT Source Type: research